The present invention relates to a recombinant virus inhibiting foot-and-mouth disease virus, and more specifically, to a recombinant adenovirus for simultaneously expressing pig interferon alpha and gamma through the insertion of foot-and-mouth disease virus 2A gene so as to allow pig interferon alpha and gamma to be treated at one time, thereby increasing inhibitory effects for foot-and-mouth disease virus.
